1009 Optimizing immunological reinvigoration in leukemic cutaneous T-cell lymphoma through use of multiple immune checkpoint inhibitors
In this study we assessed the use of multiple immune checkpoint inhibitors on the proliferation and Th1 cytokine production of CD4 and CD8 T-cells of patients with L-CTCL.
Source: Journal of Investigative Dermatology - Category: Dermatology Authors: K.K. Zhang, M. Wysocka, B. Benoit, A.H. Rook Tags: Translational Studies Source Type: research
More News: Allergy & Immunology | Cancer & Oncology | Cutaneous T cell lymphoma | Dermatology | Leukemia | Lymphoma | Skin | Study | T-cell Lymphoma